Stocks and Investing
Stocks and Investing
Wed, November 15, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kristen Kluska Maintained (TSHA) at Buy with Increased Target to $7 on, Nov 15th, 2023
Kristen Kluska of Cantor Fitzgerald, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $6 to $7 on, Nov 15th, 2023.
Kristen has made no other calls on TSHA in the last 4 months.
There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Kristen
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $5 on, Wednesday, September 20th, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $5 on, Wednesday, September 20th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, September 20th, 2023
- Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Tuesday, August 15th, 2023
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Tuesday, August 15th, 2023
- Jack Allen of "Baird" Maintained at Buy with Increased Target to $8 on, Tuesday, August 15th, 2023
Contributing Sources